• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Breast Cancer

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

by Syed Hamza Sohail 03/22/2023 Leave a Comment

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

What You Should Know: - A recent study published in JAMA found that conventional genomic tests commonly used for breast cancer tumors can be less accurate for Black women. This news comes at a time when Black women with breast cancer are experiencing mortality rates that are 41% higher than white women. - Dr. Nathalie Johnson, MD FACS and President of The American Society of Breast Cancer Surgeons is among numerous doctors who advocate for Agendia and its tests which look beyond race,
Read More

Maribel Health Raises $25M to Create the Future of Advanced Care at Home

by Jasmine Pennic 03/15/2023 Leave a Comment

Maribel Health Raises $25M to Create the Future of Advanced Care at Home

What You Should Know: - Maribel Health, a turnkey partner for health systems looking to design, build, and operate a full continuum of advanced home and community services, announced today the completion of a $25 million Series A funding round led by General Catalyst.  - The new funding will be used to accelerate growth with Maribel's initial partners, to attract and onboard the talent required to serve its collaborators worldwide and to support continued
Read More

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

by Syed Hamza Sohail 03/13/2023 Leave a Comment

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

What You Should Know: - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution. - Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More

Why Researchers Should Explore New Apps of Machine Learning

by Michael Munsell, Director of Research at Panalgo 02/08/2023 Leave a Comment

Why Researchers Should Explore New Apps of Machine Learning

As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights. In fact, in a recent survey, 95% of life sciences executives said they expect to utilize ML in the next few years to generate real-world evidence (RWE) from this data.  With such a large and growing volume of data available, researchers may be wondering how they can take advantage of all of it to enhance and expand the
Read More

5 Key Trends in Women’s Health Technology for 2023 to Watch

by Sylvia Kang, co-founder and CEO of Mira 02/07/2023 Leave a Comment

key trends in women’s health technology for 2023

Women's healthcare faces an uphill battle after centuries of being ignored. Yet, ironically enough, women currently share half of the consumerism market, hold power over 80% of household financial decisions, and make 70% of healthcare-related choices in their families. Despite this, their access to proper healthcare often comes up short. But with the market for women's healthcare predicted to be worth over $47 billion, changes are starting to occur. And with the recent attacks and laws on
Read More

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

by Syed Hamza Sohail 02/06/2023 Leave a Comment

Biden Admin Builds on Cancer Moonshot with 13 More Initiatives

What You Should Know: - One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today. - The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More

Praying For The Survival of the NHS Will Not Be Enough To Save It

by Ivor Campbell, CEO of Snedden Campbell 01/24/2023 Leave a Comment

What Has COVID Ever Done For Us?

It’s often said that the National Health Service is the closest thing Britain has to a unifying religion. If that is the case, then the faith of the population is being tested like never before, With budgets already stretched before the COVID pandemic, additional cost pressures since heaped on health boards across the country by double-digit inflation have brought the NHS closer to breaking point than at any time in its history. Every passing day seems to bring bleaker news for the
Read More

Medical Natural Language Processing Tech Has Come of Age

by Dr. Tim O’Connell, Founder & CEO of emtelligent 01/19/2023 Leave a Comment

Medical Natural Language Processing Tech Has Come of Age

For many years, natural language processing (NLP) has held the promise of dramatically increasing the ability of healthcare organizations to quickly and accurately understand unstructured medical text in clinical notes. Using medical NLP, healthcare providers, clinical researchers, and payers would uncover meaningful insights hidden in unstructured text faster, with fewer errors, and at less cost than manual data review and analysis. This high-quality medical-grade data in turn would drive
Read More

Ibex Study Finds AI Highly Accurate in Cancer Identification

by Syed Hamza Sohail 12/14/2022 Leave a Comment

Ibex Study Finds AI Highly Accurate in Cancer Identification

What You Should Know: - The latest study from Ibex Medical Analytics and the Institut Curie, published in Nature, demonstrates how AI implementation across pathology labs can significantly improve the outcome of cancer care. - The study analyzed Ibex’s AI-based quality control solution for breast biopsy review on over 15,000 slides over a diverse cohort. The study found the AI algorithm achieved high accuracy in identifying various types of cancer and 51 different morphological features of
Read More

New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages

by Syed Hamza Sohail 12/06/2022 Leave a Comment

New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages

What You Should Know: - Exai Bio and researchers at UCSF released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and smallest tumor sizes. - Earlier detection of breast cancer is crucial for optimal patient outcomes but cannot always be achieved based on symptoms or mammography. Non-Invasive Blood-Based Platform Delivers Promising Data on Detecting Breast Cancer At It’s Earliest Stages Exai Bio is a
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |